


Point-of-Care Testing for COVID-19

The Character of Rheumatology Has Changed Over the Past 50 Years

The History of ACE Inhibitors in Scleroderma Renal Crisis

The ARP Revises Its Fundamentals of Rheumatology Course

The Effects of IL-17A Inhibitors on the Microbiota

Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis

The Unapproved-Drugs Initiative Is Coming to an End

A New $1 Million Endowed Chair Honors Dr. Richard M. Silver

Research Coordinators Offer a Lot to Clinical Rheumatology Research Teams

Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

Study Finds Renal Arteriosclerosis Is Common in Lupus Nephritis Patients

Diagnostic Drill-Down: New Research Suggests Genetic Autoinflammatory Roots

Late-Breaking Abstract Session Spans the Realm of Drug-Related Research

MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA

Smart, Stem Cell-Based Implants May Revolutionize the Treatment of Arthritis

B Cell Depletion: The Latest Information on Disease Processes, Therapies

Tell a Convincing Story: Tips from the Experts on How to Secure Research Grants

Interfering with Interferon: Experts Discuss IFN Signaling & IFN Inhibition Treatment Possibilities

The Psychosocial Toll of COVID-19

Case Report: Drug-Induced Lupus & ANCA-Associated Vasculitis Overlap

Study Finds NSAIDs Raise Heart Disease Risk in Osteoarthritis Patients

The ACR’s 2020 Advocacy Year in Review

Reporting & Other Tips for the CARES Act Provider Relief Fund

Rheum After 5: Dr. Angus Worthing, the Singing Rheumatologist

Risankizumab May Improve Symptoms of PsA
